Jadelle Access Program

Transcription

1 Example for a collaboration with donor and procurer community UNFPA Supplier Workshop, Sept. 2013, Copenhagen, DK Annette Velleuer, Bayer HealthCare Pharmaceuticals Berlin, Germany

2 The London Family Planning Summit July 2012 KEY FACTS Over 150 leaders from governments, donors, civil society, private sector 23 governments made commitments to address policy, financing, delivery barriers 26 foundations/donors made new financial commitments of $2.6 billion over 8 years New financial commitments from country governments totaled $2.0 billion 1,292 NGOs from 177 countries signed the Civil Society Declaration Source: USAID/PRH Stakeholders Meeting February 4, 2013 Page 2 BHC Pharmaceuticals, Annette Velleuer 2013

3 Unmet Need for FP Methods Remaining Did you know, that* at least 200 million women want to use safe and effective FP methods, but are unable to do so because they lack access to products/services or the support of their husbands and communities. And more than 50 million of the 190 million women who become pregnant each year have abortions. Many of these are clandestine and performed under unsafe conditions. Worldwide, some 14 million children are born every year to young married and unmarried women aged 15 to 19. The absolute number of married women who either use contraception or who have an unmet need for FP is projected to grow from 900 million in 2010 to 962 million in 2015, and will increase in most developing countries. Need new approaches to address supply hurdles and increase awareness *Source: UNFPA, Aug 2012, The Lancet, Early Online Publication, 12 March 2013, Page 3 BHC Pharmaceuticals, Annette Velleuer 2013

4 Increase access to modern contraceptives Family Planning Summit 2012 Source: MSI used Impact calculator 2, to estimate the impact of achieving the London Summit on Family Planning pledge of sustaining 260 million users and reaching an additional 120 million users with different method mixes. Page 4 BHC Pharmaceuticals, Annette Velleuer 2013

5 Bayer s Social HealthCare Programs Partner for Reproductive Health Bayer s commitment to societal needs: Serving public markets and social marketing projects to ensure access to contraceptives in less developed countries CSI a public private partnership as an opportunity for high- quality COC for 2 nd Tier Marketing With our FP Programs and educational activities, we are supporting the UN Millennium Development Goals #3, #4 & #5* Bayer offers a broad range of different high quality WHO pre-qualified products (OCs, Injectable, Implants) as well as knowhow, skills and global networking. Bayer s initiatives contribute to global health and combine sustainable market growth with important access to medicines. *(Promote gender equality and empower women, Reduce child mortality, Improve maternal health) Page 5 BHC Pharmaceuticals, Annette Velleuer 2013

6 Acknowledgements Melinda Gates, Co-chair of the Bill & Melinda Gates Foundation In July 2012, global leaders pledged to provide women around the world with greater access to more contraceptive options, and today, we are one step closer to delivering on this promise. We hope this will be the first of many innovative partnerships that will help give women and girls the power to create better lives for themselves and their families. Prof. Dr. Wolfgang Plischke, Head of Bayer HealthCare AG, Member of Board of Directors Innovation is the key to our commercial success. At the same time the basis of our social commitment. With this initiative we want to make a substantial contribution to improving the health of women and children in developing countries. Page 6 BHC Pharmaceuticals, Annette Velleuer 2013

7 27 Mio implants for 6 years ( ) Chronology The London Family Planning Summit 2012 End of July 2012 the contract negotiations started Memorandum of understanding signed Announcement September 26, 2012 at the United Nations in New York Final contract between Bill&Melinda Gates Foundation and Bayer signed Jadelle Access Program with the USD 8,50 price ex works effective from January 1, 2013 Page 7 BHC Pharmaceuticals, Annette Velleuer 2013

8 27 Mio implants for 6 years ( ) From left to right: Former U.S. President Bill Clinton (Clinton Health Access Initiative), Dr Raj Shah, USAID Administrator, Scott Sherriff (speaking) Head SBE WHC,Bayer HealthCare, Justine Greening, UK Secretary State for International Development, Jens Stoltenberg, Prime Minister of Norway and President Goodluck Jonathan of Nigeria. Source: Sep , Announcement at United Nations, New York Page 8 BHC Pharmaceuticals, Annette Velleuer 2013

9 Facts & Figures Contract partner Bill & Melinda Gates Foundation Volume Guarantee for Jadelle for with a total of 27 Mio units Price reduction of more than 50% over the next six years: US$18 US$8.50 ex works per unit Effective from 1 January 2013, in more than 50 developing countries where the 1x10 package is registered or can be brought in through waiver process Partnership between Bayer, the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative (CHAI), the Governments of Norway, the United Kingdom, the United States and Sweden, and the Children s Investment Fund Foundation (CIFF) and the United Nations Population Fund (UNFPA) Page 9 BHC Pharmaceuticals, Annette Velleuer 2013

10 Media Highlights February 28 Media Announcement Op-ed about Jadelle Access Program authored by Dr. Bashir Issak from Kenya placed in 26 outlets in 15 African countries 8 original stories about the partnership ran in national, regional & international outlets (Think Africa, The Standard (Kenya), The Post (Cameroon), Huffington Post) November 7 th Event Jadelle Access Program media & stakeholder event to be held in Nairobi, Kenya, just days before the International Conference on Family Planning in Addis Will frame partnership as FP2020 success story & aim to generate regional coverage Page 10 BHC Pharmaceuticals, Annette Velleuer 2013

11 Contribution to Health When fully implemented, the Jadelle Access Program can help prevent more than 28 million unintended pregnancies between 2013 and 2018 while adverting 280,000 infant and 30,000 maternal deaths In total an estimated US$250 million will be saved in global health costs Helping to create a better life for women and girls in less resourced countries of the world 1x10 sets of 2 sub dermal implants (2 flexible rods, each containing 75mg Levonorgestrel); delivered with disposable trocar with CE mark for each insertion; first implants WHO prequalified since Sep09; free distribution in public sector *Source: Jadelle Press Release, February 27, 2013 Page 11 BHC Pharmaceuticals, Annette Velleuer 2013

12 General Conditions PRICE 8.50 USD per unit including the disposable trocar per each unit. ex-works as of January 1, 2013 onwards for all customers STANDARD PACKAGE 10 units of 2 implants 10 PILs English-French-Spanish 1 SPC leaflet 1 instruction for insertion and removal 10 Patient reminder cards EXTRAs E.g. stickers, are not included in the 8.50 USD price Will therefore be charged to customer Page 12 BHC Pharmaceuticals, Annette Velleuer 2013

13 Ordering Process UNFPA assigned an item focal point to work with Bayer OY coordinating demand and supply of Jadelle Bayer OY receive an offer / inquiry from the customer Offer / inquiry is placed into the production planning Customer recieves delivery date, volume and weight for the offer The agreement is ex works, Bayer OY assists e.g.unfpa with freight forwardring arrangements Offer / inquiry remains in the production plan IMPORTANT This doesn t hold production capacity until the confirmed order /PO is placed Production is continously running based on the volume agreed in the contract Page 13 BHC Pharmaceuticals, Klaus Brill, 2013

14 Ordering Process More orders then production capacity at a given point in time Bayer OY informs the customer immediately about the new delivery date Customers double check with the country the stock situation Customer provides Bayer OY with information which delivery should be postponed Customer delivers a country priority list to Bayer OY IMPORTANT Information exchange and close collaboration between the customer and Bayer OY Page 14 BHC Pharmaceuticals, Klaus Brill, 2013

15 Establishing End to End Visibility for Jadelle Now that we have the right product at the right price, reaching FP2020 goals will require that we get the right quantity of Jadelle to the right countries in the right condition and at the right time As demand increases we need to align orders to forecasts that are based on a combination of consumption, service capacity and demographic projections as well as budgets We will likely experience competing demands so need to balance demand with supply across different procurement agencies to ensure we can serve as many clients as possible With so many different partners involved, this needs careful coordination, trust, information sharing and collaboration It will need constant adjustment and flexibility while meeting agency administrative requirements 15

16 Model for Jadelle Supply Chain Collaboration UNFPA/DFID USAID RHSC/ BMGF Bayer Procurement Initial production agreement Production Business Benefits: Country forecasts submitted Production planning Better transparency Country forecasts analyzed Better alignment between supply and demand Purchase Orders placed by UNFPA & USAID Country forecasts updated Collaborate on aligning supply and demand Production to Purchase Orders Updated production planning Better communication Joint problem solving Better order fulfillment Reduced product expiry Donor Guarantors 16

17 Ordering Process Bayer Pharma AG Customer Freight Forwarder Bayer OY (on behalf of Bayer Pharma AG): - receives order Purchase Order (PO) Freight Order - receives order - confirms order - prepares documents required - communicates date for pick-up - receives date for pick-up from customer - ensures availability of goods at external warehouse - pick-up of goods at external - invoices goods Invoice Goods Payment Goods - delivery to country of destination Invoice Freight Payment Freight - invoices freight Page 17 BHC Pharmaceuticals, Annette Velleuer 2013

18 Deliveries + Confirmed orders* + Offers* exceed 3.0 million units ( units) Deliveries + Confirmed orders* +offers* as of August 2, 2013 Implants in units Total units*: Production FC USAID ~0.5 mio. UNFPA ~2.2 mio. Others** ~0.3 mio. ~.3.1 mio Quarter 1 Quarter 2 Quarter 3 Quarter 4 The guarantee of 3.0 mio. units in 2013 covered by the contract has been met Certainty from the agreement allowed Bayer to produce and actually exceed expected capacity *Confirmed orders are defined as following: purchase order and shipping document received country wise. Offers are defined as following: inquiries, order pending ** others: Crown Agents, Imres, PSI, different national MoH, tender Page 18 BHC Pharmaceuticals, Annette Velleuer 2013

19 Training Bayer Pharma AG together with Jhpiego, an affiliate of the John Hopkins University, will implement Jadelle training program for HCPs The USD 8,50 price does not cover training costs Pictures (fltr): Jadelle Training on insertion and removal in Senegal and Mozambique Page 19 BHC Pharmaceuticals, Annette Velleuer 2013

20 Good Practices Donor commitment for a volume guarantee Manufacturer commitment for a price reduction based on the volume guarantee Reliable forecasting from the countries headquarters e.g. UN Timely forecasting Supply chain Strong collaboration between purchase organizations and manufacturer Increase of implant training for Healthcare Providers funded by donors Outreach to media & stakeholders can help raise awareness among target audiences in key donor & developing countries Page 20 BHC Pharmaceuticals, Annette Velleuer 2013

21 Thank You For Your Attention! Picture: 150 Years Science For A Better Life, Bayer Anniversary Tour Page 21 BHC Pharmaceuticals, Annette Velleuer 2013

22